Outcomes of Immune Checkpoint Inhibitors in Patients with Cancer and a Poor Performance Status #445

J Palliat Med. 2022 Sep;25(9):1440-1442. doi: 10.1089/jpm.2022.0275.
No abstract available

MeSH terms

  • Humans
  • Immune Checkpoint Inhibitors
  • Immunotherapy
  • Lung Neoplasms* / drug therapy
  • Neoplasms* / drug therapy

Substances

  • Immune Checkpoint Inhibitors